Диссертация (1150042), страница 21
Текст из файла (страница 21)
Plasma lipoproteins: genetic influences and clinical implications.// Nat. Rev.Genet. - 2009. - V. 10. - P.109-121.45 Xua Y., Hoa W., Xud F., Wene T. Exploratory investigation reveals parallel alteration ofplasma fatty acids and eicosanoids in coronary artery disease patients.// Prostaglandins & Other104Lipid Mediators.
– 2013. – V.106. –P. 29–3646. Munir R., Usman H., Hasnain S., Smans K. , Kalbacher H. et al. Atypical plasma lipid profilein cancer patients: Cause or consequence?// Biochimie. - 2014. –V.X. - P. 1-1047. Rysman E., Brusselmans K., Scheys K., Timmermans L. et al. De novo lipogenesis protectscancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation. //Cancer Res. – 2010.
- V. 70. - P. 8117-812648. Ventura R., Mordec K., Waszczuk J., Wang Z. et al. Inhibition of de novo Palmitate Synthesis by Fatty Acid Synthase Induces Apoptosis in Tumor Cells by Remodeling Cell Membranes,Inhibiting Signaling Pathways, and Reprogramming Gene Expression. // EBioMedicine. 2015. –V.2.
- №8. – P.808-824.49. Mocelina M., Camargoa C.Q. et al. A systematic review and meta-analysis of the n-3 polyunsaturated fatty acids effects on inflammatory markers in colorectal cancer.// Clinical Nutrition.Available online 29 April 201550. Caia F., Sorg O., Grancia V., Lecumberria E. et al. Interaction of ω-3 polyunsaturated fattyacids with radiation therapy in two different colorectal cancer cell lines.// Clinical Nutrition. 2014. - V. 33. – P.
164–170.51. Sawada N., Inoue M., Iwasaki M., Sasazuki S. et al. Consumption of n-3 Fatty Acids andFish Reduces Risk of Hepatocellular Carcinoma. //Japan Public Health Center–Based ProspectiveStudy Group Gastroenterology. - 2012. - V. 142. - №, 7. - P. 1468–1475.52. Campa D., Husing A., Chang-Claude J., Dostal L., et al. Genetic variability of the fatty acidsynthase pathway is not associated with prostate cancer risk in the European Prospective Investigation on Cancer. //European Journal Of Cancer.
– 2011. – V. 47. – P. 420 – 42753. Jurczyszyna A., Czepielb J., Gdula-Argasińskac J., Paśkod P. et al. Plasma fatty acidprofile in multiple myeloma patients. // Leukemia Research. -2015. – V.39. – P. 400–40554 Wuwen L., Tongshu Yang, Identification of possible biomarkers for breast cancer from freefatty acid profiles determined by GC–MS and multivariate statistical analysis.
//Clinical Biochemistry. - 2012. - V. 45. - P. 127–13355. Shannona J., O’Malleya J., Moria M., Garzotto M. et al. Erythrocyte fatty acids and prostatecancer risk: A comparison of methods.// Prostaglandins, Leukotrienes and Essential Fatty Acids.- 2010. – V.183. – P. 161–16956. Sosnowski R., Zawistowski J. Plasma Phospholipid Fatty Acids and Prostate Cancer Risk inthe SELECT Trial. // European Urology. – 2014. – V.65. – P. 1012-1020.57. Chan J.M., Gann P.H., Giovannucci E.L. Role of diet in prostate cancer development and progression. //J. Clin Oncol.
– 2005. – V. 23. – P. 8152-8160.10558. Xua Y., Hoa W.E., Xud F., Wene T. et al. Exploratory investigation reveals parallel alteration of plasma fatty acids and eicosanoids in coronary artery disease patients.// Prostaglandins &Other Lipid Mediators. – 2013. – V.106. – P. 29–3659.
Lichtenstein A.H. Trans fatty acids and blood lipid levels, parameters of cholesterol metabolism, and hemostatic factors.// Nutritional Biochemistry. – 1998. – V.9. - №5. – P. 244-24860. Havmoeller R., Reinier K., Teodorescu C., Ahmadi N. et al. Elevated plasma free fatty acidsare associated with sudden death: A prospective community-based evaluation at the time of cardiacarrest. // Heart Rhythm. – 2014.
– V.11. - P. 691–69661. Oliver M.F., Opie L.H. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias.// Lancet. - 1994. – V. 343. – P.155–15862. Song T. , Changa Y., Shin M., Heo J. et al. Low levels of plasma omega 3-polyunsaturatedfatty acids are associated with cerebral small vessel diseases in acute ischemic stroke patients.
//Nutrition Research. – 2015. – V.35. - №5. – P. 368–37463. Forouhi N., Koulman A., Sharp S.J. et al. Differences in the prospective association betweenindividual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study . //The Lancet Diabetes & Endocrinology. – 2014. – V.2. – P. 810-81864.
Noorshahi N., Sotoudeh G., Djalalia M., Reza M. APOA II genotypes frequency and theirinteraction with saturated fatty acids consumption on lipid profile of patients with type 2 diabetes.//Clinical Nutrition. – 2015. - in press65. Уколов А.И., Орлова Т.И., Мигаловская Е.Д., Войтенко Н.Г., Гончаров Н.В.Метаболомика: на пути интеграции биохимии, аналитической химии, информатики //Успехи современной биологии, 2015, Т.
135, № 1, С. 3-17.66. Weinberg J.M. Lipotoxicity.// Kidney Int. - 2006. – V. 70. – P. 1560-156667 Charles M.A., Eschwège E., Thibult N., Claude J.R. et al. The role of non-esterified fatty acidsin the deterioration of glucose tolerance in Caucasian subjects: results of the Paris ProspectiveStudy. //Diabetologia. – 1997. – V. 40. - № 9. – P. 1101-1106.68. Itoh Y., Kawamata Y., Harada M., Kobayashi M. et al. Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40.// Nature.
– 2003. – V. 422. - № 6928. – P. 173176.69. Listenberger L.L., Schaffer J.E. Mechanisms of lipoapoptosis: implications for human heartdisease. //Trends Cardiovasc. Med. – 2002. – V. 12. – P. 134-138.70. Carpentier A.C. Postprandial fatty acid metabolism in the development of lipotoxicity and type2 diabetes. //Diabetes Metab. – 2008.
– V. 34. – P. 97-107.10671. Han L.D., Xia J.F., Liang Q.L., Wang Y. et al. Plasma esterified and non-esterified fatty acidsmetabolic profiling using gas chromatography-mass spectrometry and its application in the studyof diabetic mellitus and diabetic nephropathy.// Anal. Chim. Acta. – 2011. – V. 689. – P. 85-91.72. Poitout V., Hagman D., Stein R., Artner I. et al. Regulation of the insulin gene by glucose andfatty acids.// J. Nutr.
– 2006. – V. 136. – P. 873-876.73. Radin N. Killing tumours by ceramide-induced apoptosis: a critique of available drugs.// Biochem. J. – 2003. – V. 371. – P. 243–256.74. Suzuki K., Babazono T., Murata H., Iwamoto Y. Clinical significance of urinary liver-typefatty acid-binding protein in patients with diabetic nephropathy. //Diabetes Care. – 2005. – V. 28.– P. 2038-2039.75. Dabla P.K. Renal function in diabetic nephropathy.// World J.
Diabetes. – 2010. – V.1. – P.48-5676. Neuromuscular Disorders of Infancy, Childhood, and Adolescence (Second Edition) A Clinician's Approach, Chapter 40 – Lipid Storage Myopathies Due to Fatty Acid Oxidation DefectsIngrid Tein. Edited by Darras B.T., Jones H. R., Ryan M.M. and De Viv D.C. - 2015. – P. 761795.77.
Zhang H., Wang Z, Oscar Liu. Note to users Development and validation of a GC-FID methodfor quantitative analysis of oleic acid and related fatty acids// Journal of Pharmaceutical Analysis.– 2015. - In Press78. Wei G., Zeng E.Y. Gas chromatography-mass spectrometry and high-performance liquidchromatography-tandem mass spectrometry in quantifying fatty acids.// Trends in AnalyticalChemistry. - 2011. – V. 30. - No. 9. – P.
60-68.79. Shantha N.C., Napolitano. Gas chromatography of fatty acids// Journal of Chromatography. 1992. – V.624. - P. 37-5180. Shi W., Li J., He B., Yan F. et al. Biodiesel production from waste chicken fat with low freefatty acids by an integrated catalytic process of composite membrane and sodium Methoxide //Bioresource Technology. – 2013. – V. 139. – P. 316–322.81. Morrison W.R., Smith L.M. Preparation of fatty acid methyl esters þ dimethylacetals fromlipids with boron fluoride-methanol.//J.LipidRes. - 1964. - V5.
- P600–608.82. Lands W., Libelt B., Morris A., Kramer N.C. Maintenance of lower proportions of ( n - 6)eicosanoid precursors in phospholipids of human plasma in response to added dietary (n - 3) fattyacids. //.Biochimica et Biophysica Acta. - 1992. - V.1180. - P.147-162.83. Vognild E., Elvevoll E.O., Brox J., Olsen R.L.
et al. Effects of dietary marine oils and oliveoil on fatty acid composition, platelet membrane fluidity, platelet responses, and serum lipids in107healthy humans.// Lipids. - 1998. – V. 33. - P. 427-436.84. Ostermann A. I., Müller M.,Willenberg I. , HelgeScheb N. Determining the fatty acid composition in plasma and tissues as fatty acid methyl esters using gas chromatography – a comparisonof different derivatization and extraction procedures.
//Prostaglandins, Leukotrienes and EssentialFatty Acids . – 2014. - V. 91. - P. 235–241.85. Eder K. Gas chromatographic analysis of fatty acid methyl esters //Journal of ChromatographyB. - 1995. - V.671.- P. 113-131.86. Lepage G., Roy C.C. Direct transesterification of all classes of lipids in a one-step reaction.//G. Lipid Res. – 1986. – V.27. – P. 114-120.87. Bicalha B., David F., Rumplel K., Kindtd E. et al.
Creating a fatty acid methyl ester databasefor lipid profiling in a single drop of human blood using high resolution capillary gas chromatography and mass spectrometry // //J of Chromatogr A. - 2008. - V. 1211. - P. 120–128.88. Yi L., He J., Liang Y., Yuan D. et al. Simultaneously quantitative measurement of comprehensive profiles of esterified and non-esterified fatty acid in plasma of type 2 diabetic patients //Chemistry and Physics of Lipids.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
